@misc{indiciaec1ba7b6ab817,
  title = {Combined antagonism of Oncostatin M (OSM) and Interleukin 6 (IL-6) provides both anti-fibrotic and anti-inflammatory benefit in pulmonary fibrosis},
  author = {Ratsimandresy, R. A. and Doran, E. and Dengler, H. S. and Headland, S. E. and Wedeles, C. J. and Guidi, R. and Xu, D. and Liu, J. and Shi, Y. and Wang, J. and Uttarwar, S. and Abbas, A. R. and Sun, T. and DePianto, D. J. and Morshead, K. B. and Arron, J. and Rock, J. R. and Bevers, J. and Yadav, R. and Ramalingam, T. and Gao, X. and Brightbill, H. D. and Emson, C. L. and Jeet, S. and Arlantico, A. and Wong, A. and Yu, S. and Tran, T. H. and Leong, L. and Chen, W. and Dohse, M. and Austin, C. and Caplazi, P. and Panettieri, R. A. and Koziol-White, C. and Jester, W. F. and Shaw, A. and Avraham, S. and Menon, H. and Darmanis, S. and Modrusan, Z. and Kajihara, K. and Kanamori, M. and Shimada, H. and West, N. R. and Nakamura, G.},
  year = {2025},
  doi = {10.64898/2025.12.25.695625},
  url = {https://www.biorxiv.org/content/10.64898/2025.12.25.695625v1},
  note = {Source identifier: 10.64898/2025.12.25.695625}
}